Roxadustat Global Phase 3 Results for Treatment of Chronic Kidney Disease (CKD) Anemia to be Presented at American Society of Nephrology Kidney Week 2019

    NEXT STORY
    Apellis to Present Data on APL-2 in Complement 3 Glomerulopathy at ASN Kidney Week 2019
    PREV STORY
    Angion to Present Late-Breaking Data on ANG-3777 in Delayed Graft Function at the American Society of Nephrology Kidney Week 2019
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Curis Announces Presentations Related to CA-170 and CUDC-907 at 2017 ASCO Annual Meeting

    LEXINGTON, Mass., May 25, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company ...

    author_avatar
    NASDAQ Market News

    Syneos Health Consulting Releases 10th Annual Biopharmaceutical Dealmakers Survey – Predicts M&A Landscape to Continue Bull Run, While Buyers Begin to Become More Risk Averse

    BOSTON, June 05, 2018 (GLOBE NEWSWIRE) -- The tenth annual Dealmakers’ Intentions Study from ...

    author_avatar
    NASDAQ Market News

    Clinical Cancer Research Publishes Phase I Data from a Study of Rafael Pharmaceuticals’ Lead CPI-613 Compound in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia

    author_avatar
    NASDAQ Market News